MedPath

An open label single arm clinical trial to evaluate the effect of Naarikela pushpaadi kashaya in Asrugdara (Dysfunctional Uterine Bleeding)

Phase 3
Conditions
Health Condition 1: N00-N99- Diseases of the genitourinary systemHealth Condition 2: N920- Excessive and frequent menstruation with regular cycleHealth Condition 3: N920- Excessive and frequent menstruation with regular cycle
Registration Number
CTRI/2021/02/031560
Lead Sponsor
SDM college of Ayurveda and hospital Hassan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subject with menstral bleeding for more than 5 days in each cycle

Patient using more than 3 completely soaked pads per day

Intermenstrual bleeding

Subjects with signs and symptoms of Asrugdara for at least 3 months

Exclusion Criteria

Known case of threatened or incomplete abortion

Known case of coagulation and bleeding disorders

Known case of thyroid dysfunction

Known case of sexually transmitted diseases

Using intra Uterine and oral contraceptives

Known case of benign and malignant growth in uterus

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of symptoms such as excessive bleeding,prolonged bleeding,intermenstural bleeding,clotsAfter 2 months intervention (8 weeks) <br/ ><br>Assessment will be done.Timepoint: After 2 months intervention-1 month follow up
Secondary Outcome Measures
NameTimeMethod
Attainment of Regular menstruationTimepoint: 3months
© Copyright 2025. All Rights Reserved by MedPath